Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 2866
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25517(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 21nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25518(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 32nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25522(2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 42nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25519(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 48nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25523(2-[3-chloro-5-(6-{[(1S)-1-phenylethyl]amino}-1H-py...)
Affinity DataIC50: 50nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25520(1-[3-(3-aminopropyl)-5-chlorophenyl]-3-methyl-N-[(...)
Affinity DataIC50: 59nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM24926(1-(3-chlorophenyl)-3-methyl-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 121nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25514(1-(3,5-dimethylphenyl)-3-methyl-N-[(1S)-1-phenylet...)
Affinity DataIC50: 149nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25521(N-{2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]...)
Affinity DataIC50: 207nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25513(1-(3-methanesulfonylphenyl)-3-methyl-N-[(1S)-1-phe...)
Affinity DataIC50: 225nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25516(1-(3-bromo-5-chlorophenyl)-3-methyl-N-[(1S)-1-phen...)
Affinity DataIC50: 274nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25511(3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyraz...)
Affinity DataIC50: 412nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25508(1-(3-fluorophenyl)-3-methyl-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 464nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25502(3-methyl-1-(3-methylphenyl)-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 474nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK2(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25518(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 597nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25515(1-(3,5-dichlorophenyl)-3-methyl-N-[(1S)-1-phenylet...)
Affinity DataIC50: 641nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25506(1-(4-methoxyphenyl)-3-methyl-N-[(1S)-1-phenylethyl...)
Affinity DataIC50: 703nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25512(1-[3-(dimethylamino)phenyl]-3-methyl-N-[(1S)-1-phe...)
Affinity DataIC50: 977nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM24925(BMCL185648 Compound 1 | 3-methyl-1-phenyl-N-[(1S)-...)
Affinity DataIC50: 1.30E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25510(3-methyl-N-[(1S)-1-phenylethyl]-1-[3-(propan-2-yl)...)
Affinity DataIC50: 1.48E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK2(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25521(N-{2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]...)
Affinity DataIC50: 2.17E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK3(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25518(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 2.46E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25509(1-(4-fluorophenyl)-3-methyl-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 3.24E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25507(1-(2-fluorophenyl)-3-methyl-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 4.52E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25503(3-methyl-1-(4-methylphenyl)-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 4.53E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25505(1-(3-methoxyphenyl)-3-methyl-N-[(1S)-1-phenylethyl...)
Affinity DataIC50: 5.93E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetFocal adhesion kinase 1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25521(N-{2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]...)
Affinity DataIC50: 6.28E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAurora kinase A(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25521(N-{2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]...)
Affinity DataIC50: 6.80E+3nMAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetFocal adhesion kinase 1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25518(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 7.46E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25501(3-methyl-1-(2-methylphenyl)-N-[(1S)-1-phenylethyl]...)
Affinity DataIC50: 7.69E+3nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK3(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25521(N-{2-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]...)
Affinity DataIC50: 1.00E+4nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAurora kinase A(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25518(3-[3-chloro-5-(3-methyl-6-{[(1S)-1-phenylethyl]ami...)
Affinity DataIC50: 1.00E+4nMAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM25504(1-(2-methoxyphenyl)-3-methyl-N-[(1S)-1-phenylethyl...)
Affinity DataIC50: 1.45E+4nMpH: 7.2 T: 2°CAssay Description:An IMAP fluorescence polarization-based assay format (Molecular Devices) was used to determine the ability of compounds to inhibit the phosphorylatio...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed